Predictors of Bioresorbable Everolimus-Eluting Scaffold Failure at Intravascular Ultrasound Examination: Asymmetry Versus Expansion

Free article

Comment

Gianluca Caiazzo et al. JACC Cardiovasc Interv. 2016.

Free article

. 2016 Sep 26;9(18):1970-1.

doi: 10.1016/j.jcin.2016.07.010.

No abstract available

Comment in

Reply: Predictors of Bioresorbable Everolimus-Eluting Scaffold Failure at Intravascular Ultrasound Examination: Asymmetry Versus Expansion.
Suwannasom P, Sotomi Y, Onuma Y, Serruys PW. Suwannasom P, et al. JACC Cardiovasc Interv. 2016 Sep 26;9(18):1971-2. doi: 10.1016/j.jcin.2016.07.027. JACC Cardiovasc Interv. 2016. PMID: 27659576 No abstract available.

The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial.
Suwannasom P, Sotomi Y, Ishibashi Y, Cavalcante R, Albuquerque FN, Macaya C, Ormiston JA, Hill J, Lang IM, Egred M, Fajadet J, Lesiak M, Tijssen JG, Wykrzykowska JJ, de Winter RJ, Chevalier B, Serruys PW, Onuma Y. Suwannasom P, et al. JACC Cardiovasc Interv. 2016 Jun 27;9(12):1231-1242. doi: 10.1016/j.jcin.2016.03.027. Epub 2016 Jun 1. JACC Cardiovasc Interv. 2016. PMID: 27262861